TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Hiwase D, Hahn C, Tran ENH, Chhetri R, et al. Blood 2023;141:1087-1091.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hiwase D, Hahn C, Tran ENH, Chhetri R, et al. TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 2023;141:1087-1091.
PMID: 36574363